205 results on '"De Lorenzo, R."'
Search Results
2. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
- Author
-
Poletti S., Palladini M., Mazza M. G., De Lorenzo R., Irene B., Sara B., Beatrice B., Ceciclio B., Stefania C., Valentina C., Elisa C., Jacopo C., Marta C., Elena C., Federica C., Sarah D., Greta D. O., Camilla D. P., Marica F., Paola F., Anna F., Cristiano M., Sabina M., Beatrice M. E., Teresa M. E. M., Aurora M., Chiara P., Chiara S., Benedetta V., Giordano V., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F., Poletti, S., Palladini, M., Mazza, M. G., De Lorenzo, R., Irene, B., Sara, B., Beatrice, B., Ceciclio, B., Stefania, C., Valentina, C., Elisa, C., Jacopo, C., Marta, C., Elena, C., Federica, C., Sarah, D., Greta, D. O., Camilla, D. P., Marica, F., Paola, F., Anna, F., Cristiano, M., Sabina, M., Beatrice, M. E., Teresa, M. E. M., Aurora, M., Chiara, P., Chiara, S., Benedetta, V., Giordano, V., Furlan, R., Ciceri, F., Rovere-Querini, P., and Benedetti, F.
- Subjects
Neuropsychological Tests ,Cognition ,Humans ,Medicine ,Verbal fluency test ,Cognitive Dysfunction ,Pharmacology (medical) ,Cognitive skill ,Effects of sleep deprivation on cognitive performance ,Biological Psychiatry ,Psychomotor learning ,Original Paper ,Depressive Disorder, Major ,Depression ,business.industry ,Neuropsychology ,COVID-19 ,General Medicine ,Executive functions ,Patient Discharge ,Psychiatry and Mental health ,Cognitive impairment ,Memory, Short-Term ,Quality of Life ,Verbal memory ,Cognition Disorders ,business ,Clinical psychology - Abstract
Neurologic and psychiatric symptoms have been reported in the months following the infection with COVID-19. A low-grade inflammation has been associated both with depression and cognitive symptoms, suggesting a link between these disorders. The aim of the study is to investigate cognitive functioning 6 months following hospital discharge for COVID-19, the impact of depression, and the consequences on quality of life. Ninety-two COVID-19 survivors evaluated at 1-month follow-up, 122 evaluated at 3 months and 98 evaluated at 6 months performed neuropsychological and psychiatric evaluations and were compared with a healthy comparison group (HC) of 165 subjects and 165 patients with major depression (MDD). Cognitive performances were adjusted for age, sex, and education. Seventy-nine percent of COVID-19 survivors at 1 month and 75% at 3- and 6-month follow-up showed cognitive impairment in at least one cognitive function. No significant difference in cognitive performances was observed between 1-, 3-, and 6-months follow-up. COVID-19 patients performed worse than HC but better than MDD in psychomotor coordination and speed of information processing. No difference between COVID-19 survivors and MDD was observed for verbal fluency, and executive functions, which were lower than in HC. Finally, COVID-19 survivors performed the same as HC in working memory and verbal memory. The factor that most affected cognitive performance was depressive psychopathology which, in turn, interact with cognitive functions in determining quality of life. Our results confirm that COVID-19 sequelae include signs of cognitive impairment which persist up to 6 months after hospital discharge and affect quality of life. Supplementary Information The online version contains supplementary material available at 10.1007/s00406-021-01346-9.
- Published
- 2021
3. Residual lung damage following ARDS in COVID-19 ICU survivors
- Author
-
Compagnone N., Palumbo D., Cremona G., Vitali G., De Lorenzo R., Calvi M. R., Del Prete A., Baiardo Redaelli M., Calamara S., Belletti A., Steidler S., Conte C., Zangrillo A., De Cobelli F., Rovere-Querini P., Monti G., Castellani J., Cilla M., Cinel E., Di Tomasso N., Falbo E., Faustini C., Fedrizzi M., Ferrante M., Fresilli S., Landoni G., Magnaghi C., Maimeri N., Martinenghi S., Moizo E., Mucci M., Velati M., Compagnone, N., Palumbo, D., Cremona, G., Vitali, G., De Lorenzo, R., Calvi, M. R., Del Prete, A., Baiardo Redaelli, M., Calamara, S., Belletti, A., Steidler, S., Conte, C., Zangrillo, A., De Cobelli, F., Rovere-Querini, P., Monti, G., Castellani, J., Cilla, M., Cinel, E., Di Tomasso, N., Falbo, E., Faustini, C., Fedrizzi, M., Ferrante, M., Fresilli, S., Landoni, G., Magnaghi, C., Maimeri, N., Martinenghi, S., Moizo, E., Mucci, M., and Velati, M.
- Subjects
Adult ,Male ,ARDS ,chest CT scan ,medicine.medical_treatment ,critically ill patients ,pulmonary function tests ,Pulmonary function testing ,COVID‐19 ,Interquartile range ,DLCO ,Intensive care ,follow-up ,Medicine ,Humans ,Survivors ,Lung ,Research Articles ,Tidal volume ,intensive care ,follow‐up ,Mechanical ventilation ,Respiratory Distress Syndrome ,pulmonary fibrosis ,business.industry ,SARS-CoV-2 ,COVID-19 ,General Medicine ,respiratory system ,acute respiratory distress syndrome ,Middle Aged ,medicine.disease ,respiratory tract diseases ,Intensive Care Units ,Anesthesiology and Pain Medicine ,medicine.anatomical_structure ,Anesthesia ,business ,Research Article - Abstract
Background Coronavirus disease 2019 acute respiratory distress syndrome (COVID‐19 ARDS) is a disease that often requires invasive ventilation. Little is known about COVID‐19 ARDS sequelae. We assessed the mid‐term lung status of COVID‐19 survivors and investigated factors associated with pulmonary sequelae. Methods All adult COVID‐19 patients admitted to the intensive care unit from 25th February to 27th April 2020 were included. Lung function was evaluated through chest CT scan and pulmonary function tests (PFT). Logistic regression was used to identify predictors of persisting lung alterations. Results Forty‐nine patients (75%) completed lung assessment. Chest CT scan was performed after a median (interquartile range) time of 97 (89–105) days, whilst PFT after 142 (133–160) days. The median age was 58 (52–65) years and most patients were male (90%). The median duration of mechanical ventilation was 11 (6–16) days. Median tidal volume/ideal body weight (TV/IBW) was 6.8 (5.71–7.67) ml/Kg. 59% and 63% of patients showed radiological and functional lung sequelae, respectively. The diffusion capacity of carbon monoxide (DLCO) was reduced by 59%, with a median per cent of predicted DLCO of 72.1 (57.9–93.9) %. Mean TV/IBW during invasive ventilation emerged as an independent predictor of persistent CT scan abnormalities, whilst the duration of mechanical ventilation was an independent predictor of both CT and PFT abnormalities. The extension of lung involvement at hospital admission (evaluated through Radiographic Assessment of Lung Edema, RALE score) independently predicted the risk of persistent alterations in PFTs. Conclusions Both the extent of lung parenchymal involvement and mechanical ventilation protocols predict morphological and functional lung abnormalities months after COVID‐19.
- Published
- 2022
4. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI)
- Author
-
Corradini E., Ventura P., Ageno W., Cogliati C. B., Muiesan M. L., Girelli D., Pirisi M., Gasbarrini A., Angeli P., Querini P. R., Bosi E., Tresoldi M., Vettor R., Cattaneo M., Piscaglia F., Brucato A. L., Perlini S., Martelletti P., Pontremoli R., Porta M., Minuz P., Olivieri O., Sesti G., Biolo G., Rizzoni D., Serviddio G., Cipollone F., Grassi D., Manfredini R., Moreo G. L., Pietrangelo A., Teatini T., Salvetti M., Crisafulli E., Sainaghi P. P., Zileri Dal Verme L., Piano S., De Lorenzo R., Arcidiacono G., Podda M., Muratori L., Gabiati C., Salinaro F., Luciani M., Barnini C., Morra di Cella S., Dalbeni A., Friso S., Mearelli F., Malerba P., Cavallone F., D'Ardes D., Notargiacomo S., De Giorgi A., Mansi M., Buzzetti E., Ricci A., Martelli F., Corradini E., Ventura P., Ageno W., Cogliati C.B., Muiesan M.L., Girelli D., Pirisi M., Gasbarrini A., Angeli P., Querini P.R., Bosi E., Tresoldi M., Vettor R., Cattaneo M., Piscaglia F., Brucato A.L., Perlini S., Martelletti P., Pontremoli R., Porta M., Minuz P., Olivieri O., Sesti G., Biolo G., Rizzoni D., Serviddio G., Cipollone F., Grassi D., Manfredini R., Moreo G.L., Pietrangelo A., Teatini T., Salvetti M., Crisafulli E., Sainaghi P.P., Zileri Dal Verme L., Piano S., De Lorenzo R., Arcidiacono G., Podda M., Muratori L., Gabiati C., Salinaro F., Luciani M., Barnini C., Morra di Cella S., Dalbeni A., Friso S., Mearelli F., Malerba P., Cavallone F., D'Ardes D., Notargiacomo S., De Giorgi A., Mansi M., Buzzetti E., Ricci A., Martelli F., Corradini, E., Ventura, P., Ageno, W., Cogliati, C. B., Muiesan, M. L., Girelli, D., Pirisi, M., Gasbarrini, A., Angeli, P., Rovere-Querini, P., Bosi, E., Tresoldi, M., Vettor, R., Cattaneo, M., Piscaglia, F., Brucato, A. L., Perlini, S., Martelletti, P., Pontremoli, R., Porta, M., Minuz, P., Olivieri, O., Sesti, G., Biolo, G., Rizzoni, D., Serviddio, G., Cipollone, F., Grassi, D., Manfredini, R., Moreo, G. L., Pietrangelo, A., Teatini, T., Salvetti, M., Crisafulli, E., Sainaghi, P. P., Zileri Dal Verme, L., Piano, S., De Lorenzo, R., Arcidiacono, G., Podda, M., Muratori, L., Gabiati, C., Salinaro, F., Luciani, M., Barnini, C., Morra di Cella, S., Dalbeni, A., Friso, S., Mearelli, F., Malerba, P., Cavallone, F., D'Ardes, D., Notargiacomo, S., De Giorgi, A., Mansi, M., Buzzetti, E., Ricci, A., and Martelli, F.
- Subjects
Mortality from COVID-19 ,Comorbidity ,030204 cardiovascular system & hematology ,Cohort Studies ,0302 clinical medicine ,80 and over ,Medicine ,030212 general & internal medicine ,Hospital Mortality ,Internal medicine ,Comorbidity, Internal medicine, Mortality from COVID-19, Polypharmacy, SARS-CoV-2 ,Aged, 80 and over ,LS7_9 ,Mortality rate ,Respiration ,Middle Aged ,Hospitals ,Survival Rate ,Hospitalization ,Italy ,Polypharmacy ,SARS-CoV-2 ,Cohort ,Artificial ,Emergency Medicine ,Adult ,Aged ,COVID-19 ,Critical Care ,Humans ,Respiration, Artificial ,Internal Medicine ,medicine.symptom ,Cohort study ,medicine.medical_specialty ,Settore MED/12 - GASTROENTEROLOGIA ,Socio-culturale ,03 medical and health sciences ,Intensive care ,Survival rate ,business.industry ,Organ dysfunction ,Settore MED/09 - MEDICINA INTERNA ,medicine.disease ,Im - Original ,business - Abstract
During the COVID-19 2020 outbreak, a large body of data has been provided on general management and outcomes of hospitalized COVID-19 patients. Yet, relatively little is known on characteristics and outcome of patients managedin Internal Medicine Units (IMU). To address this gap, the Italian Society of Internal Medicine has conducted a nationwide cohort multicentre study on death outcome in adult COVID-19 patients admitted and managed in IMU. This study assessed 3044 COVID-19 patients at 41 referral hospitals across Italy from February 3rd to May 8th 2020. Demographics, comorbidities, organ dysfunction, treatment, and outcomes including death were assessed. During the study period, 697 patients (22.9%) were transferred to intensive care units, and 351 died in IMU (death rate 14.9%). At admission, factors independently associated with in-hospital mortality were age (OR 2.46, p = 0.000), productive cough (OR 2.04, p = 0.000), pre-existing chronic heart failure (OR 1.58, p = 0.017) and chronic obstructive pulmonary disease (OR 1.17, p = 0.048), the number of comorbidities (OR 1.34, p = 0.000) and polypharmacy (OR 1.20, p = 0.000). Of note, up to 40% of elderly patients did not report fever at admission. Decreasing PaO2/FiO2 ratio at admission was strongly inversely associated with survival. The use of conventional oxygen supplementation increased with the number of pre-existing comorbidities, but it did not associate with better survival in patients with PaO2/FiO2 ratio
- Published
- 2021
5. AB0564 PROGNOSTIC ROLE OF PRE-CONCEPTIONAL COMPLEMENT CONSUMPTION ON PREGNANCY OUTCOMES IN ANTI-PHOSPHOLIPID ANTIBODY SYNDROME, POLIABORTIVITY AND RECURRENT IMPLANTATION FAILURE
- Author
-
Canti, V., primary, De Lorenzo, R., additional, Gerbino, C., additional, Adorno, G., additional, Pasi, F., additional, Castiglioni, M. T., additional, and Rovere-Querini, P., additional
- Published
- 2022
- Full Text
- View/download PDF
6. AB0448 ADVERSE PREGNANCY OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE ROLE OF THERAPY.
- Author
-
Cilona, M. B., primary, Canti, V., additional, Dalpiaz, I., additional, De Lorenzo, R., additional, Inguscio, G., additional, Asperti, C., additional, Rosa, S., additional, Castiglioni, M. T., additional, and Rovere-Querini, P., additional
- Published
- 2022
- Full Text
- View/download PDF
7. OP0125 THE MANAGEMENT OF PREGNANCY IN AUTOIMMUNE RHEUMATIC DISEASES: ANALYSIS OF 758 PREGNANCIES FROM THE PROSPECTIVE NATIONWIDE P-RHEUM.IT STUDY (THE ITALIAN REGISTRY OF PREGNANCY IN THE RHEUMATIC DISEASES)
- Author
-
Andreoli, L., primary, Gerardi, M. C., additional, Crisafulli, F., additional, Zanetti, A., additional, Rozza, D., additional, Gerosa, M., additional, Lini, D., additional, Filippini, M., additional, Fredi, M., additional, Nalli, C., additional, Lazzaroni, M. G., additional, Taglietti, M., additional, Franceschini, F., additional, Caporali, R., additional, Trespidi, L., additional, Erra, R., additional, Mosca, M., additional, Tani, C., additional, Zucchi, D., additional, Melissa, P., additional, Ruffilli, F., additional, Maranini, B., additional, Rovere-Querini, P., additional, Canti, V., additional, De Lorenzo, R., additional, Cutro, M. S., additional, Picerno, V., additional, Montecucco, C., additional, Ramoni, V., additional, Anelli, M. G., additional, Abbruzzese, A., additional, Serale, F., additional, Romeo, N., additional, Chimenti, M. S., additional, Cuomo, G., additional, Larosa, M., additional, Pata, A. P., additional, Iuliano, A., additional, Crepaldi, G., additional, Brucato, A., additional, Landolfi, G., additional, Carrara, G., additional, Bortoluzzi, A., additional, Scirè, C. A., additional, and Tincani, A., additional
- Published
- 2022
- Full Text
- View/download PDF
8. AB0445 THE BENEFICIAL EFFECTS OF THERAPY ON OBSTETRICAL OUTCOME AND PLACENTAL HISTOLOGY IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: THE EXPERIENCE OF A SINGLE ITALIAN REFERENCE CENTER
- Author
-
Canti, V., primary, Inguscio, G., additional, Tenace, N. P., additional, Lucianò, R., additional, De Lorenzo, R., additional, Cilona, M. B., additional, Pozzoni, M., additional, Cavoretto, P. I., additional, Castiglioni, M. T., additional, and Rovere-Querini, P., additional
- Published
- 2022
- Full Text
- View/download PDF
9. Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1)
- Author
-
Spagnuolo V., Guffanti M., Galli L., Poli A., Querini P. R., Ripa M., Clementi M., Scarpellini P., Lazzarin A., Tresoldi M., Dagna L., Zangrillo A., Ciceri F., Castagna A., Andolina A., Redaelli M. B., Baldissera E., Bigai G., Bigoloni A., Boffini N., Borio G., Bossolasco S., Bruzzesi E., Calabro M. G., Calvisi S., Campochiaro C., Canetti D., Canti V., Castellani J., Castiglioni B., Cavalli G., Cavallo L., Cernuschi M., Chiurlo M., Cilla M., Cinel E., Cinque P., Conte C., Da Prat V., Danise A., De Lorenzo R., De Luca G., Dell'Acqua A., Dell'Acqua R., Della-Torre E., Torre L. D., Di Terlizzi G., Dumea I., Farolfi F., Ferrante M., Frangi C., Fumagalli L., Gallina G., Germinario B., Gianotti N., Hasson H., Lalla F., Landoni G., Lanzillotta M., Voti R. L., Mastrangelo A., Messina E., Moizo E., Montagna M., Monti G., Morsica G., Muccini C., Nozza S., Oltolini C., Pascali M., Patrizi A., Pieri M., Prestifilippo D., Ramirez G., Ranzenigo M., Sapienza J., Sartorelli S., Seghi F., Tambussi G., Din C. T., Tomelleri A., Turi S., Uberti-Foppa C., Vinci C., Spagnuolo, V., Guffanti, M., Galli, L., Poli, A., Querini, P. R., Ripa, M., Clementi, M., Scarpellini, P., Lazzarin, A., Tresoldi, M., Dagna, L., Zangrillo, A., Ciceri, F., Castagna, A., Andolina, A., Redaelli, M. B., Baldissera, E., Bigai, G., Bigoloni, A., Boffini, N., Borio, G., Bossolasco, S., Bruzzesi, E., Calabro, M. G., Calvisi, S., Campochiaro, C., Canetti, D., Canti, V., Castellani, J., Castiglioni, B., Cavalli, G., Cavallo, L., Cernuschi, M., Chiurlo, M., Cilla, M., Cinel, E., Cinque, P., Conte, C., Da Prat, V., Danise, A., De Lorenzo, R., De Luca, G., Dell'Acqua, A., Dell'Acqua, R., Della-Torre, E., Torre, L. D., Di Terlizzi, G., Dumea, I., Farolfi, F., Ferrante, M., Frangi, C., Fumagalli, L., Gallina, G., Germinario, B., Gianotti, N., Hasson, H., Lalla, F., Landoni, G., Lanzillotta, M., Voti, R. L., Mastrangelo, A., Messina, E., Moizo, E., Montagna, M., Monti, G., Morsica, G., Muccini, C., Nozza, S., Oltolini, C., Pascali, M., Patrizi, A., Pieri, M., Prestifilippo, D., Ramirez, G., Ranzenigo, M., Sapienza, J., Sartorelli, S., Seghi, F., Tambussi, G., Din, C. T., Tomelleri, A., Turi, S., Uberti-Foppa, C., and Vinci, C.
- Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2021
10. Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19: Adiponectin and leptin in COVID-19
- Author
-
Di Filippo L., De Lorenzo R., Sciorati C., Capobianco A., Lore N. I., Giustina A., Manfredi A. A., Rovere-Querini P., Conte C., Di Filippo, L., De Lorenzo, R., Sciorati, C., Capobianco, A., Lore, N. I., Giustina, A., Manfredi, A. A., Rovere-Querini, P., and Conte, C.
- Subjects
Inflammation ,Leptin ,Male ,SARS-CoV-2 ,Diabetes ,Humans ,COVID-19 ,Female ,Adiponectin ,Obesity ,Prospective Studies ,Survival Analysis - Abstract
Aim: Obesity is a risk factor for COVID-19, but the underlying mechanisms are unclear. We investigated the role of adiponectin (an anti-inflammatory adipokine), leptin (a pro-inflammatory adipokine) and their ratio (Adpn/Lep) in this context. Design: Single-centre, prospective observational study. Methods. Adiponectin and leptin were measured in 60 COVID-19 patients with mild (not hospitalised, n=11), moderate (hospitalised but not requiring intensive care, n=25) and severe (admission to the intensive care unit [ICU] or death, n=24) disease. Results: Adiponectin and leptin levels were similar across severity groups, but patients with moderate severity had the highest Adpn/Lep ratio (1.2 [0.5; 2.0], 5.0 [1.6; 11.2], 2.1 [1.0; 3.6] in mild, moderate and severe disease; P = 0.019). Adpn/Lep, but not adiponectin or leptin alone, correlated with systemic inflammation (C reactive protein, CRP: Spearman's rho 0.293, P = 0.023). When dividing patients into Adpn/Lep tertiles, adiponectin was highest, whereas leptin was lowest in the third (highest) tertile. Patients in the highest Adpn/Lep tertile had numerically lower rates of obesity, diabetes and hypertension, and lower rates of death or admission to ICU versus other tertiles. At linear regression in the whole cohort, CRP significantly predicted Adpn/Lep (β 0.291, P = 0.022), while female gender (β -0.289, P = 0.016), diabetes (β -0.257, P = 0.028), and hypertension (β -239, P = 0.043) were negative predictors. Conclusions: We speculate that the rise in Adpn/Lep, due to increased adiponectin and reduced leptin, is a compensatory response to systemic inflammation. In patients with worse cardiometabolic health (e.g. diabetes, hypertension) this mechanism might be blunted, possibly contributing to higher mortality.
- Published
- 2021
11. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
- Author
-
Spagnuolo, V., Guffanti, M., Galli, L., Poli, A., Querini, P. Rovere, Ripa, M., Clementi, M., Scarpellini, P., Lazzarin, A., Tresoldi, Moreno, Dagna, L., Zangrillo, A., Ciceri, F., Castagna, A., Andolina, A., Redaelli, M. Baiardo, Baldissera, E., Bigai, G., Bigoloni, A., Boffini, N., Borio, G., Bossolasco, S., Bruzzesi, E., Calabrò, M. G., Calvisi, S., Campochiaro, C., Canetti, D., Canti, V., Castellani, J., Castiglioni, B., Cavalli, G., Cavallo, L., Cernuschi, M., Chiurlo, M., Cilla, M., Cinel, E., Cinque, P., Conte, C., Da Prat, V., Danise, A., De Lorenzo, R., De Luca, G., Dell’Acqua, A., Dell’Acqua, R., Torre, E. Della, Torre, L. Della, Di Terlizzi, G., Dumea, I., Farolfi, F., Ferrante, M., Frangi, C., Fumagalli, L., Gallina, G., Germinario, B., Gianotti, Nicola, Hasson, H., Lalla, F., LANDONI, Giovanni, Lanzillotta, M., Voti, R. Li, Mastrangelo, A., Messina, E., Moizo, E., Montagna, M., Monti, G., Morsica, G., Muccini, C., Nozza, S., Oltolini, C., Pascali, M., Patrizi, A., Pieri, M., Prestifilippo, D., Ramirez, Giuseppe Alvise, Ranzenigo, M., Sapienza, J., Sartorelli, S., Seghi, F., Tambussi, G., Din, C. Tassan, Tomelleri, A., Turi, S., Uberti-Foppa, C., Vinci, C., COVID-BioB study group, Spagnuolo, V., Guffanti, M., Galli, L., Poli, A., Querini, P. R., Ripa, M., Clementi, M., Scarpellini, P., Lazzarin, A., Tresoldi, M., Dagna, L., Zangrillo, A., Ciceri, F., Castagna, A., Andolina, A., Redaelli, M. B., Baldissera, E., Bigai, G., Bigoloni, A., Boffini, N., Borio, G., Bossolasco, S., Bruzzesi, E., Calabro, M. G., Calvisi, S., Campochiaro, C., Canetti, D., Canti, V., Castellani, J., Castiglioni, B., Cavalli, G., Cavallo, L., Cernuschi, M., Chiurlo, M., Cilla, M., Cinel, E., Cinque, P., Conte, C., Da Prat, V., Danise, A., De Lorenzo, R., De Luca, G., Dell'Acqua, A., Dell'Acqua, R., Torre, E. D., Torre, L. D., Di Terlizzi, G., Dumea, I., Farolfi, F., Ferrante, M., Frangi, C., Fumagalli, L., Gallina, G., Germinario, B., Gianotti, N., Hasson, H., Lalla, F., Landoni, G., Lanzillotta, M., Voti, R. L., Mastrangelo, A., Messina, E., Moizo, E., Montagna, M., Monti, G., Morsica, G., Muccini, C., Nozza, S., Oltolini, C., Pascali, M., Patrizi, A., Pieri, M., Prestifilippo, D., Ramirez, G., Ranzenigo, M., Sapienza, J., Sartorelli, S., Seghi, F., Tambussi, G., Din, C. T., Tomelleri, A., Turi, S., Uberti-Foppa, C., and Vinci, C.
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Coronavirus disease 2019 (COVID-19) ,Lymphocyte ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Corticosteroid treatment ,Severe disease ,Diseases ,030204 cardiovascular system & hematology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Adrenal Cortex Hormones ,Internal medicine ,medicine ,Humans ,In patient ,030212 general & internal medicine ,Pandemics ,Aged ,Retrospective Studies ,Multidisciplinary ,business.industry ,Proportional hazards model ,Age Factors ,COVID-19 ,Retrospective cohort study ,Middle Aged ,Viral Load ,Publisher Correction ,COVID-19 Drug Treatment ,Hospitalization ,Treatment Outcome ,Infectious diseases ,Viral infection ,medicine.anatomical_structure ,Italy ,Female ,business - Abstract
The aim of this study was to evaluate the impact of early treatment with corticosteroids on SARS-CoV-2 clearance in hospitalized COVID-19 patients. Retrospective analysis on patients admitted to the San Raffaele Hospital (Milan, Italy) with moderate/severe COVID-19 and availability of at least two nasopharyngeal swabs. The primary outcome was the time to nasopharyngeal swab negativization. A multivariable Cox model was fitted to determine factors associated with nasopharyngeal swab negativization. Of 280 patients included, 59 (21.1%) patients were treated with steroids. Differences observed between steroid users and non-users included the proportion of patients with a baseline PaO2/FiO2 ≤ 200 mmHg (45.8% vs 34.4% in steroids and non-steroids users, respectively; p = 0.023) or ≤ 100 mmHg (16.9% vs 12.7%; p = 0.027), and length of hospitalization (20 vs 14 days; p 2/FiO2 > 200 mmHg, and a lymphocyte count at admission > 1.0 × 109/L. SARS-CoV-2 clearance was not associated with corticosteroid use. Our study shows that delayed SARS-CoV-2 clearance in moderate/severe COVID-19 is associated with older age and a more severe disease, but not with an early use of corticosteroids.
- Published
- 2020
12. Predicting early mortality of COVID-19 patients of the first pandemic wave based on automatically extracted lung densitometry parameters
- Author
-
Fiorino, C., primary, Mori, M., additional, Palumbo, D., additional, De Lorenzo, R., additional, Broggi, S., additional, Compagnone, N., additional, Guazzarotti, G., additional, Esposito, P.G., additional, Mazzilli, A., additional, Steidler, S., additional, Vitali, G.P., additional, Del Vecchio, A., additional, Querini, P.R., additional, and De Cobelli, F., additional
- Published
- 2021
- Full Text
- View/download PDF
13. Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease
- Author
-
Rovere-Querini P., De Lorenzo R., Conte C., Brioni E., Lanzani C., Yacoub M. R., Chionna R., Martinenghi S., Vitali G., Tresoldi M., Ciceri F., Rovere-Querini, P., De Lorenzo, R., Conte, C., Brioni, E., Lanzani, C., Yacoub, M. R., Chionna, R., Martinenghi, S., Vitali, G., Tresoldi, M., and Ciceri, F.
- Subjects
Male ,Pneumonia, Viral ,COVID-19 ,Outpatient ,Follow up ,Middle Aged ,Ambulatory Care Facilities ,Hospitalization ,Betacoronavirus ,Humans ,Female ,Prospective Studies ,Coronavirus Infections ,Pandemics ,Aged ,Follow-Up Studies - Abstract
Background and aim of the work: The coronavirus disease-19 (COVID-19) outbreak is posing considerable challenges to healthcare systems and societies worldwide. While the knowledge on the acute phase of the disease has rapidly expanded, little is known on the consequences of COVID-19 following clinical remission. We set up a multidisciplinary COVID-19 follow-up outpatient clinic to identify and address the clinical needs of COVID-19 survivors. Here we describe the features of our follow-up programme. Methods: The multidisciplinary assessment comprises a complete physical examination, respiratory evaluation (peripheral oxygen saturation, respiratory rate, dyspnoea assessment, lung ultrasound and pulmonary function), cardiovascular assessment (electrocardiography, echocardiography), nutritional assessment (anthropometrics, mini Nutritional Assessment screening tool), neurological examination including cognitive tests, and mental health assessment. All data are prospectively collected, and blood is sampled for biobanking. Results: Since 7 April to 5 June, 2020, 453 out of the 1388 COVID-19 survivors managed at our University Hospital have been evaluated at the Outpatient COVID-19 Follow-up Clinic. The characteristics of the follow-up cohort are similar to those of the whole cohort of COVID-19 in terms of demographics, comorbidities, and COVID-19 severity upon ED presentation, indicating that the follow-up cohort is representative of the whole cohort. Conclusions: Continuous patient monitoring might give an answer to the numerous unsolved questions about what comes next in this pandemic and beyond. This will help physicians and researchers establish strategies to face future pandemics and develop preventative and therapeutic strategies for similar hyperinflammatory conditions. (www.actabiomedica.it).
- Published
- 2020
14. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19
- Author
-
Gherlone, E.F., primary, Polizzi, E., additional, Tetè, G., additional, De Lorenzo, R., additional, Magnaghi, C., additional, Rovere Querini, P., additional, and Ciceri, F., additional
- Published
- 2021
- Full Text
- View/download PDF
15. AB0567 CHARACTERIZATION OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY AND MYOCARDIAL INVOLVEMENT: A MONO-CENTRIC EXPERIENCE.
- Author
-
De Lorenzo, R., primary, Cavalli, S., additional, Bonomi, F., additional, Tronci, S., additional, Calvisi, S. L., additional, Previtali, S., additional, and Rovere-Querini, P., additional
- Published
- 2020
- Full Text
- View/download PDF
16. The immunology of the fetal–placental unit comes of age
- Author
-
De Lorenzo, R., primary, Canti, V., additional, Manfredi, A. A., additional, and Rovere‐Querini, P., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Safety of fertility treatments in women with systemic autoimmune diseases (SADs)
- Author
-
Vanni, VS, primary, De Lorenzo, R, additional, Privitera, L, additional, Canti, V, additional, Viganò, P, additional, and Rovere-Querini, P, additional
- Published
- 2019
- Full Text
- View/download PDF
18. Using spectral reflectance to distinguish between tracheal and oesophageal tissue: applications for airway management
- Author
-
Nawn, C. D., primary, Blackburn, M. B., additional, De Lorenzo, R. A., additional, and Ryan, K. L., additional
- Published
- 2019
- Full Text
- View/download PDF
19. 115. Feasibility study for In-Vivo Dosimetry procedure in routine clinical practice
- Author
-
Falco, M.D., primary, Giancaterino, S., additional, De Nicola, A., additional, Adorante, N., additional, De Lorenzo, R. Gimenez, additional, Di Tommaso, M., additional, Vinciguerra, A., additional, Trignani, M., additional, Allajbej, A., additional, Greco, F., additional, Grusio, M., additional, Genovesi, D., additional, and Piermattei, A., additional
- Published
- 2018
- Full Text
- View/download PDF
20. 218. Jarvik2000 and radiotherapy. Irradiation with high-energy photon beams and first results
- Author
-
De Lorenzo, R. Giménez, primary, Navarra, R., additional, Marinelli, D., additional, Adorante, N., additional, Giancaterino, S., additional, Genovesi, D., additional, Giammarco, G. Di, additional, and Falco, M.D., additional
- Published
- 2018
- Full Text
- View/download PDF
21. OD105 - Predicting early mortality of COVID-19 patients of the first pandemic wave based on automatically extracted lung densitometry parameters
- Author
-
Fiorino, C., Mori, M., Palumbo, D., De Lorenzo, R., Broggi, S., Compagnone, N., Guazzarotti, G., Esposito, P.G., Mazzilli, A., Steidler, S., Vitali, G.P., Del Vecchio, A., Querini, P.R., and De Cobelli, F.
- Published
- 2021
- Full Text
- View/download PDF
22. The Prevalence of Diarrhea and Its Association With Drug Use in Elderly Outpatients: A Multicenter Study
- Author
-
Pilotto, A, Franceschi, M, Vitale, D, Zaninelli, A, Di Mario, F, Seripa, D, Rengo, F, FIRI e. SOFIA Project Investigators, Barbagallo, M, Bavazzano, A, Bernabei, R, Biagini, C, Cucinotta, D, Guizzardi, G, Granchi, F, Laguzzi, E, Masotti, G, Maugeri, D, Mazzei, B, Nicìta, MV, Nieddu, A, Noro, G, Olivari, G, Palummeri, E, Policicchio, D, Postacchini, D, Putzu, P, Tardi, S, Abbiati, C, Alpa, A, Antiga, I, Antonina, MR, Arnaboldi, L, Ballotti, E, Bargellini, N, Barisone, G, Battelli, M, Beccari, G, Bitetti, E, Bologni, A, Bongera, P, Bortot, M, Bracalenti, L, Buonono, G, Busolo, M, Campanini, MC, Caputo, L, Cartei, A, Cascavilla, P, Casciaro, L, Casula, E, Cesarone, L, Chiesa, D, Chiumeo, F, Ciciarello, A, Cincotta, G, Corò, G, Corona, S, Corsini, M, Cosola, C, Dainese, A, Danza, M, De Bastiani, R, De Cesare, P, De Facci, G, De Lorenzo, R, De Vuono, AD, Della Piccola, P, D'Errico, G, Di Benedetto, G, Dodaro, M, Ercolino, M, Fatarella, P, Fazzari, F, Fiorese, G, Foco, G, Formicola, G, Franchi, F, Fronges, D, Gaetano, MA, Giordano, G, Guarino, M, Guasti, D, Kuel, AM, Kusanovic, M, Lanzavecchia, D, Lofiego, MC, Lorenzano, E, Losi, C, Magrini, F, Mancini, NM, Mander, A, Manneschi, M, Marchi, R, Maronato, G, Marsala, V, Mascia, R, Matuonto, V, Mauceri, ML, Mazzi, PA, Mezzapica, A, Mochi, F, Molenda, G, Morelli, F, Morsia, D, Mosna, MC, Muglia, A, Murgia, P, Muscetta, M, Muscetta, S, Nucci, P, Olimpi, G, Orro, W, Poletto, C, Palmieri, IP, Pastacaldi, G, Pastori, C, Pieresca, G, Pietragalla, M, Pilo, S, Poggesi, S, Poli, L, Ricciardi, A, Riggi, V, Romano, V, Rossi, T, Saccarello, A, Salatino, A, Salvati, R, Sannino, A, Santelli, M, Santucci, A, Saponaro, GM, Schergna, A, Schiavone, C, Sammarco, R, Scornavacca, G, Serena, D, Silvino, G, Sistilli, L, Soldan, S, Soro, A, Tatti, R, Tempestini, L, Testini, D, Tibeloli Carnevali, A, Toniolo, B, Torselli, R, Tremul, L, Trevisan, F, Trifilò, P, Cimenti, T, Valente, S, Vannucchi, CE, Vencato, PG, Vigotti, G, Virdis, G, Zaccaro, F, Zanzot, S, Zingone, FM, Zirillo, AM, ANNONI, GIORGIO, Pilotto, A, Franceschi, M, Vitale, D, Zaninelli, A, Di Mario, F, Seripa, D, Rengo, F, FIRI e., S, Annoni, G, Barbagallo, M, Bavazzano, A, Bernabei, R, Biagini, C, Cucinotta, D, Guizzardi, G, Granchi, F, Laguzzi, E, Masotti, G, Maugeri, D, Mazzei, B, Nicìta, M, Nieddu, A, Noro, G, Olivari, G, Palummeri, E, Policicchio, D, Postacchini, D, Putzu, P, Tardi, S, Abbiati, C, Alpa, A, Antiga, I, Antonina, M, Arnaboldi, L, Ballotti, E, Bargellini, N, Barisone, G, Battelli, M, Beccari, G, Bitetti, E, Bologni, A, Bongera, P, Bortot, M, Bracalenti, L, Buonono, G, Busolo, M, Campanini, M, Caputo, L, Cartei, A, Cascavilla, P, Casciaro, L, Casula, E, Cesarone, L, Chiesa, D, Chiumeo, F, Ciciarello, A, Cincotta, G, Corò, G, Corona, S, Corsini, M, Cosola, C, Dainese, A, Danza, M, De Bastiani, R, De Cesare, P, De Facci, G, De Lorenzo, R, De Vuono, A, Della Piccola, P, D'Errico, G, Di Benedetto, G, Dodaro, M, Ercolino, M, Fatarella, P, Fazzari, F, Fiorese, G, Foco, G, Formicola, G, Franchi, F, Fronges, D, Gaetano, M, Giordano, G, Guarino, M, Guasti, D, Kuel, A, Kusanovic, M, Lanzavecchia, D, Lofiego, M, Lorenzano, E, Losi, C, Magrini, F, Mancini, N, Mander, A, Manneschi, M, Marchi, R, Maronato, G, Marsala, V, Mascia, R, Matuonto, V, Mauceri, M, Mazzi, P, Mezzapica, A, Mochi, F, Molenda, G, Morelli, F, Morsia, D, Mosna, M, Muglia, A, Murgia, P, Muscetta, M, Muscetta, S, Nucci, P, Olimpi, G, Orro, W, Poletto, C, Palmieri, I, Pastacaldi, G, Pastori, C, Pieresca, G, Pietragalla, M, Pilo, S, Poggesi, S, Poli, L, Ricciardi, A, Riggi, V, Romano, V, Rossi, T, Saccarello, A, Salatino, A, Salvati, R, Sannino, A, Santelli, M, Santucci, A, Saponaro, G, Schergna, A, Schiavone, C, Sammarco, R, Scornavacca, G, Serena, D, Silvino, G, Sistilli, L, Soldan, S, Soro, A, Tatti, R, Tempestini, L, Testini, D, Tibeloli Carnevali, A, Toniolo, B, Torselli, R, Tremul, L, Trevisan, F, Trifilò, P, Cimenti, T, Valente, S, Vannucchi, C, Vencato, P, Vigotti, G, Virdis, G, Zaccaro, F, Zanzot, S, Zingone, F, and Zirillo, A
- Subjects
Diarrhea ,Drug ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,health care facilities, manpower, and services ,media_common.quotation_subject ,MEDLINE ,Internal medicine ,Outpatients ,Prevalence ,medicine ,Humans ,Psychiatry ,Aged ,media_common ,Polypharmacy ,Hepatology ,business.industry ,Gastroenterology ,social sciences ,humanities ,Multicenter study ,elderly outpatients, drug use, Diarrhea ,MED/09 - MEDICINA INTERNA ,medicine.symptom ,business - Abstract
OBJECTIVES: To evaluate the prevalence of diarrhea and its association with drug use in elderly outpatients. METHODS: The study was carried out by 133 general practitioners (GPs) who referred to 24 geriatric units in Italy. The demographic data, disability, gastrointestinal symptoms, and current medications were evaluated using a structured interview, including the evaluation of the activities of daily living (ADL), the instrumental activities of daily living (IADL), and the gastrointestinal symptoms rating scale (GSRS). RESULTS: The study included 5,387 elderly subjects who regularly completed the structured interview. In total, 488 patients (9.1% of the whole population, 210 men and 278 women, mean age 75.6 6.2 yr, range 65–100 yr) reported diarrhea, that is, items 11 and 12 of the GSRS, during the 7-day period before the interview. The prevalence of diarrhea significantly increased with older age (P= 0.025), the severity of ADL (P < 0.0001) and IADL disability (P < 0.0001), and the number of drugs taken (P= 0.0002). A multivariate analysis demonstrated that the presence of diarrhea was significantly associated with the use of antibiotics (odds ratio [OR] 4.58, 95% confidence interval [CI] 1.95–10.73), proton pump inhibitors (OR 2.97, 95% CI 2.03–4.35), allopurinol (OR 2.19, 95% CI 1.26–3.81), psycholeptics (OR 1.82, 95% CI 1.26–2.61), selective serotonin reuptake inhibitors (OR 1.71, 95% CI 1.01–2.89), and angiotensin II receptor blockers (OR 1.46, 95% CI 1.08–1.99), also accounting for sex, age, and the use of antidiarrheal agents and drugs for functional gastrointestinal disorders. CONCLUSION: Diarrhea is a common problem in elderly outpatients. Its prevalence increases with old age, the severity of disability, and the number of drugs. Monitoring the presence of diarrhea and its complications in elderly patients who need treatments with drugs significantly associated with diarrhea may be clinically useful.
- Published
- 2008
23. FRI0421 Toll like receptor-7/8 activation exacerbates murine experimental autoimmune myositis
- Author
-
De Lorenzo, R., primary, Sciorati, C., additional, Monno, A., additional, Doglio, M.G., additional, Rigamonti, E., additional, Ascherman, D., additional, Manfredi, A., additional, and Rovere-Querini, P., additional
- Published
- 2018
- Full Text
- View/download PDF
24. EP-1900: Hippocampal sparing in Fractionated Stereotactic Brain VMAT RadioTherapy
- Author
-
Falco, M.D., primary, Giancaterino, S., additional, D'Andrea, M., additional, Gimenez De Lorenzo, R., additional, Trignani, M., additional, Caravatta, L., additional, Di Carlo, C., additional, Di Biase, S., additional, Allajbej, A., additional, and Genovesi, D., additional
- Published
- 2018
- Full Text
- View/download PDF
25. EP-2165: Preliminary results of Jarvik 2000 irradiation with high-energy photon beams
- Author
-
Gimenez De Lorenzo, R., primary, Navarra, R., additional, Marinelli, D., additional, Adorante, N., additional, Giancaterino, S., additional, Genovesi, D., additional, Di Giammarco, G., additional, and Falco, M.D., additional
- Published
- 2018
- Full Text
- View/download PDF
26. EP-1755: In-Vivo Dosimetry: A Feasibility Study in Routine Clinical Practice
- Author
-
Falco, M.D., primary, Giancaterino, S., additional, De Nicola, A., additional, Adorante, N., additional, Gimenez De Lorenzo, R., additional, Di Tommaso, M., additional, Vinciguerra, A., additional, Trignani, M., additional, Allajbej, A., additional, Greco, F., additional, Grusio, M., additional, Piermattei, A., additional, and Genovesi, D., additional
- Published
- 2018
- Full Text
- View/download PDF
27. EP-1964: Use of 4DCBCT Symmetry Elekta to evaluate organ motion and set-up error in lung SBRT. A pilot study
- Author
-
Di Carlo, C., primary, Nuzzo, M., additional, Allajbej, A., additional, Jimenez De Lorenzo, R., additional, Taraborrelli, M., additional, Caravatta, L., additional, Trignani, M., additional, Falco, M.D., additional, and Genovesi, D., additional
- Published
- 2018
- Full Text
- View/download PDF
28. The single particle dynamics of iodine in the Sachs-Teller regime: An inelastic x-ray scattering study.
- Author
-
Izzo, M. G., Bencivenga, F., Cunsolo, A., Di Fonzo, S., Verbeni, R., and De Lorenzo, R. Gimenez
- Subjects
PARTICLE dynamics ,IODINE ,X-ray scattering ,MOLECULAR spectra ,CHEMISTRY experiments ,CHEMICAL kinetics - Abstract
The high frequency dynamics of liquid iodine has been investigated by deep inelastic x-ray scattering at exchanged wave-vectors (q) ranging from 2.5 to 15 Å
-1 . The experimental data have been analyzed in the frame of the Sachs-Teller theory of the molecular spectrum while accounting for final state corrections to the lineshape. The performed data analysis carries insights on physical quantities as relevant as the mean rototranslational kinetic energy and the mean square Laplacian of the intermolecular potential. In both cases the measured values are consistent with corresponding theoretical expectations. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
29. Qualitative and quantitative differences in multiple HDR brachytherapy application to locally advanced cervical cancer
- Author
-
De Lorenzo, R. Gimenez, primary, Enfasi, M., additional, Cocco, G., additional, Spagnoletti, G., additional, and Bove, G., additional
- Published
- 2016
- Full Text
- View/download PDF
30. Scabies, boring skin and psyche : a situation report
- Author
-
Beltraminelli, H, Widmer, A F, Jordan, X, Strub, C, Bircher, A J, De Lorenzo, R, Herold, R, Schuhmacher, H, Buehlmann, M, and Itin, P
- Published
- 2009
31. 'Cartografia e Catasto Napoleonico. Uno studio sulla Provincia di Napoli'
- Author
-
Galluccio, Floriana, DE LORENZO, R, and Scarpa, L.
- Subjects
geografia politico-amministrativa ,geografia politico-amministrativa, catasto napoleonico, GIS ,catasto napoleonico ,GIS - Published
- 2008
32. Fiumare Joniche. Paesaggio e visibilità
- Author
-
Zagari, F., Versace, A., Gioffrè, V., Greco, R., De Lorenzo, R., Licastro, D., Guerricchio, A., Perazzi, A., Gioffrè, M. F., DEL POZZO, Antonio, and Zappia, R.
- Published
- 2005
33. Validazione analitica dell'IPA nel particolato atmosferico
- Author
-
Bortoli A., De Lorenzo R., Formenton G., Trevisan G., Vidali M., Taroni G., and Bellomi T.
- Published
- 2003
34. X-ray emission from plasma produced by a Nd:YAG/glass laser on a Cu target: a preliminary analysis
- Author
-
Palladino, L., primary, De Lorenzo, R. Gimenez, additional, Luciani, D., additional, and Limongi, T., additional
- Published
- 2010
- Full Text
- View/download PDF
35. Scabies, Boring Skin and Psyche
- Author
-
Beltraminelli, H., primary, Widmer, A.F., additional, Jordan, X., additional, Strub, C., additional, Bircher, A.J., additional, De Lorenzo, R., additional, Herold, R., additional, Schuhmacher, H., additional, Buehlmann, M., additional, and Itin, P., additional
- Published
- 2009
- Full Text
- View/download PDF
36. Experimental layout for the realization of an X-ray plasma source driven by a Nd:YAG laser for biological and medical applications
- Author
-
Palladino, L., primary, Limongi, T., additional, Gualtieri, G., additional, Gimenez De Lorenzo, R., additional, and Zuppella, P., additional
- Published
- 2008
- Full Text
- View/download PDF
37. Mass gathering medicine: a review.
- Author
-
De Lorenzo RA and De Lorenzo, R A
- Published
- 1997
- Full Text
- View/download PDF
38. Lessons in emergency evacuation from the Miamisburg train derailment.
- Author
-
De Lorenzo RA, Augustine JJ, De Lorenzo, R A, and Augustine, J J
- Published
- 1996
- Full Text
- View/download PDF
39. Medic for the millennium: the U.S. Army 91W health care specialist.
- Author
-
De Lorenzo, R A
- Abstract
The new millennium challenges the Army Medical Department to provide good care in a variety of circumstances from peacetime to operations other than war to combat. To provide care in this broad variety of missions, the Army Medical Department needs flexible providers. The new 91W health care specialist enlisted medic is designed to meet this need. By coupling skills in emergency care, evacuation, medical force protection, and primary care with certification in emergency medical technology, the 91W initiative will fill the needs of the Army now and into the new millennium.
- Published
- 2001
40. Mass casualty triage knowledge of military medical personnel.
- Author
-
Janousek, J T, Jackson, D E, De Lorenzo, R A, and Coppola, M
- Abstract
During battlefield and mass casualty incidents, triage has been traditionally performed by many different personnel, including medics, nurses, dentists, and physicians. The objective of this study was to determine which military medical providers are most knowledgeable in mass casualty triage. The design was a prospective, written, timed, case-based examination of triage knowledge. Participants were volunteers from the active duty medical (physician), dental, nursing, and enlisted corps of the three military services. Subjects completed a 16-minute written examination consisting of seven cases in each of three simulated mass casualty scenarios: combat; nuclear, biological, and chemical; and humanitarian. Tests were taken anonymously, although demographic data on medical specialty, training, and experience were collected. Participants were instructed to classify the cases using the NATO categories of immediate, delayed, minimal, or expectant. Scores were tabulated according to two grading scales: an absolute scale of number correct, and a weighted scale amplifying gross misclassifications. Median scores between groups were tested pairwise using the Kruskal-Wallis one-way analysis of variance with p < or = 0.05. Statistically significant differences were noted between the highest and lowest scoring groups in each scenario. Our conclusion is that among the subject groups tested, physicians were best at mass casualty triage. Dentists, nurses, and medics scored progressively less well on our examination.
- Published
- 1999
41. Improving combat casualty care and field medicine: focus on the military medic.
- Author
-
De Lorenzo, R A
- Abstract
As military medicine in general copes with a rapidly changing world environment, so too must the backbone of the medical force, the enlisted medic. To meet these challenges, the training and utilization of military medics must match new and different missions. This paper will explore innovative approaches to training and preparing for combat casualty care and field medicine. The focus will fall on the education, evaluation, operations, patient-care skills, equipment, and telemedicine potential of the military medic. Future directions for study and development will be suggested. Exploration of the following may improve the capability of the military medic: (1) improved training to include advanced-level skills and interventions for combat casualty care and broader exposure to the casualties expected in operations other than war; (2) annual educational and periodic proficiency evaluation requirements; (3) strengthened medical control at all echelons; and (4) carefully selected additional equipment and technologies to enhance medical capabilities.
- Published
- 1997
42. A.99 - Qualitative and quantitative differences in multiple HDR brachytherapy application to locally advanced cervical cancer.
- Author
-
De Lorenzo, R. Gimenez, Enfasi, M., Cocco, G., Spagnoletti, G., and Bove, G.
- Published
- 2016
- Full Text
- View/download PDF
43. Army aeromedical crash rates.
- Author
-
De Lorenzo, R A, Freid, R L, and Villarin, A R
- Abstract
Safety is a principal concern for everyone in aviation, including those in military and civilian aeromedical programs. The U.S. Army flies thousands of helicopter missions each year, including many aeromedical flights. The comparison between Army general and aeromedical aviation crash data provides a benchmark for establishing patterns in aeromedical safety and may be useful for similar programs examining safety profiles.
- Published
- 1999
44. Subject: military disaster medicine.
- Author
-
De Lorenzo, R
- Published
- 1998
45. One-year mental health outcomes in a cohort of COVID-19 survivors
- Author
-
Elena Mazza, Beatrice Bravi, Giordano Vitali, Valentina Canti, Federica Colombo, Rebecca De Lorenzo, Marica Ferrante, Mariagrazia Palladini, Marco Paolini, Francesco Benedetti, Fabio Ciceri, Elisa Melloni, Greta D'orsi, Elisa Caselani, Veronica Aggio, Benedetta Vai, Irene Bollettini, Jacopo Castellani, S. Martinenghi, Stefania Calvisi, Mario Gennaro Mazza, Camilla Di Pasquasio, Patrizia Rovere-Querini, Roberto Furlan, Sarah Damanti, Elena Cinel, Paola Fiore, Sara Poletti, Federico Calesella, Chiara Santini, Marta Cilla, Mazza, M. G., Palladini, M., De Lorenzo, R., Bravi, B., Poletti, S., Furlan, R., Ciceri, F., Vai, B., Bollettini, I., Melloni, E. M. T., Mazza, E. B., Aggio, V., Calesella, F., Paolini, M., Caselani, E., Colombo, F., D'Orsi, G., Di Pasquasio, C., Fiore, P., Calvisi, S., Canti, V., Castellani, J., Cilla, M., Cinel, E., Damanti, S., Ferrante, M., Martinenghi, S., Santini, C., Vitali, G., Rovere-Querini, P., and Benedetti, F.
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,SARS-CoV-2 ,Depression ,COVID-19 ,Anxiety ,Mental health ,Article ,Psychiatry and Mental health ,Distress ,Cohort ,medicine ,medicine.symptom ,business ,Biological Psychiatry ,Depression (differential diagnoses) ,Disease burden ,Fatigue ,Cohort study ,Psychopathology - Abstract
COVID-19 survivors are at increased risk of persistent psychopathology after the infection. Despite long-term sequelae are an increasing concern, long-term neuropsychiatric consequences remain largely unclear. This cohort study aimed at investigating the psychopathological impact of COVID-19 in Italy one year after infection, outlining the trajectory of symptomatology at one, six-, and twelve-months follow-up. We evaluated 402, 216, and 192 COVID-19 survivors respectively at one, six, and 12 months. A subgroup of 95 patients was evaluated longitudinally both at one, six, and 12 months. Validated self-report questionnaires were administered to assess depression, fatigue, anxiety, and post-traumatic distress. Socio-demographics and setting of care information were gathered for each participant. At six and twelve months, respectively 94 (44%) and 86 (45%) patients self-rated in the clinical range in at least one psychopathological dimension. Pathological fatigue at twelve months was detected in 63 patients (33%). Considering the longitudinal cohort an interaction effect of sex and time was observed for depression (F = 8.63, p < 0.001) and anxiety (F = 5.42, p = 0.005) with males showing a significant increasing trend of symptoms, whereas an opposite course was observed in females. High prevalence of psychiatric sequelae six and 12 months after COVID-19 was reported for the first time. These findings confirm the need to provide integrated multidisciplinary services to properly address long-lasting mental health sequelae of COVID-19 and to treat them with the aim of reducing the disease burden and related years of life lived with disability.
- Published
- 2021
46. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity
- Author
-
Andrea Giustina, Luigi di Filippo, Rebecca De Lorenzo, Giordano Vitali, Patrizia Rovere-Querini, Emanuele Bosi, Marica Ferrante, Elena Cinel, Caterina Conte, S. Martinenghi, Marta Cilla, Elisabetta Falbo, Di Filippo, L., De Lorenzo, R., Cinel, E., Falbo, E., Ferrante, M., Cilla, M., Martinenghi, S., Vitali, G., Bosi, E., Giustina, A., Rovere-Querini, P., and Conte, C.
- Subjects
Male ,medicine.medical_specialty ,Waist ,Coronavirus disease 2019 (COVID-19) ,Endocrinology, Diabetes and Metabolism ,Medicine (miscellaneous) ,030209 endocrinology & metabolism ,Overweight ,Article ,03 medical and health sciences ,0302 clinical medicine ,Weight loss ,Internal medicine ,medicine ,Humans ,Obesity ,Prospective Studies ,Survivors ,030212 general & internal medicine ,Adiposity ,Aged ,Nutrition and Dietetics ,Anthropometry ,business.industry ,COVID-19 ,Weight Fluctuation ,Middle Aged ,medicine.disease ,Hospitalization ,Italy ,Obesity, Abdominal ,Female ,Body-Weight Trajectory ,Waist Circumference ,medicine.symptom ,business ,Weight gain - Abstract
Background: COVID-19 is associated with unintentional weight loss. Little is known on whether and how patients regain the lost weight. We assessed changes in weight and abdominal adiposity over a three-month follow-up after discharge in COVID-19 survivors. Methods: In this sub-study of a large prospective observational investigation, we collected data from individuals who had been hospitalized for COVID-19 and re-evaluated at one (V1) and three (V2) months after discharge. Patient characteristics upon admission and anthropometrics, waist circumference and hunger levels assessed during follow-up were analyzed across BMI categories. Results: One-hundred-eighty-five COVID-19 survivors (71% male, median age 62.1 [54.3; 72.1] years, 80% with overweight/obesity) were included. Median BMI did not change from admission to V1 in normal weight subjects (−0.5 [−1.2; 0.6] kg/m2, p = 0.08), but significantly decreased in subjects with overweight (−0.8 [−1.8; 0.3] kg/m2, p < 0.001) or obesity (−1.38 [−3.4; −0.3] kg/m2, p < 0.001; p < 0.05 vs. normal weight or obesity). Median BMI did not change from V1 to V2 in normal weight individuals (+0.26 [−0.34; 1.15] kg/m2, p = 0.12), but significantly increased in subjects with overweight (+0.4 [0.0; 1.0] kg/m2, p < 0.001) or obesity (+0.89 [0.0; 1.6] kg/m2, p < 0.001; p = 0.01 vs. normal weight). Waist circumference significantly increased from V1 to V2 in the whole group (p < 0.001), driven by the groups with overweight or obesity. At multivariable regression analyses, male sex, hunger at V1 and initial weight loss predicted weight gain at V2. Conclusions: Patients with overweight or obesity hospitalized for COVID-19 exhibit rapid, wide weight fluctuations that may worsen body composition (abdominal adiposity). ClinicalTrials.gov registration: NCT04318366.
- Published
- 2021
47. Evaluation of Muscle Mass and Stiffness with Limb Ultrasound in COVID-19 Survivors
- Author
-
Sarah Damanti, Marta Cilla, Bruno Tuscano, Rebecca De Lorenzo, Giuseppina Manganaro, Aurora Merolla, Giacomo Pacioni, Chiara Pomaranzi, Valeria Tiraferri, Sabina Martinenghi, Giordano Vitali, Emanuele Bosi, Caterina Conte, Andrea Giustina, Moreno Tresoldi, Patrizia Rovere Querini, Damanti, S., Cilla, M., Tuscano, B., De Lorenzo, R., Manganaro, G., Merolla, A., Pacioni, G., Pomaranzi, C., Tiraferri, V., Martinenghi, S., Vitali, G., Bosi, E., Conte, C., Giustina, A., Tresoldi, M., and Rovere Querini, P.
- Subjects
COVID - 19 ,Male ,Sarcopenia ,muscle ,Endocrinology, Diabetes and Metabolism ,muscle quality ,Diseases of the endocrine glands. Clinical endocrinology ,Muscular Diseases ,Humans ,Muscle Strength ,Survivors ,Muscle, Skeletal ,Aged ,Ultrasonography ,Aged, 80 and over ,ultrasound ,SARS-CoV-2 ,COVID-19 ,Extremities ,Organ Size ,Middle Aged ,RC648-665 ,Cross-Sectional Studies ,muscle mass ,Italy ,Female - Abstract
Backgroundacute illnesses, like COVID-19, can act as a catabolic stimulus on muscles. So far, no study has evaluated muscle mass and quality through limb ultrasound in post-COVID-19 patients.Methodscross sectional observational study, including patients seen one month after hospital discharge for SARS-CoV-2 pneumonia. The patients underwent a multidimensional evaluation. Moreover, we performed dominant medial gastrocnemius ultrasound (US) to characterize their muscle mass and quality.Resultstwo hundred fifty-nine individuals (median age 67, 59.8% males) were included in the study. COVID-19 survivors with reduced muscle strength had a lower muscle US thickness (1.6 versus 1.73 cm, p =0.02) and a higher muscle stiffness (87 versus 76.3, p = 0.004) compared to patients with normal muscle strength. Also, patients with reduced Short Physical Performance Battery (SPPB) scores had a lower muscle US thickness (1.3 versus 1.71 cm, p = 0.01) and a higher muscle stiffness (104.9 versus 81.07, p = 0.04) compared to individuals with normal SPPB scores. The finding of increased muscle stiffness was also confirmed in patients with a pathological value (≥ 4) at the sarcopenia screening tool SARC-F (103.0 versus 79.55, p < 0.001). Muscle stiffness emerged as a significant predictor of probable sarcopenia (adjusted OR 1.02, 95% C.I. 1.002 – 1.04, p = 0.03). The optimal ultrasound cut-offs for probable sarcopenia were 1.51 cm for muscle thickness (p= 0.017) and 73.95 for muscle stiffness (p = 0.004).Discussionwe described muscle ultrasound characteristics in post COVID-19 patients. Muscle ultrasound could be an innovative tool to assess muscle mass and quality in this population. Our preliminary findings need to be confirmed by future studies comparing muscle ultrasound with already validated techniques for measuring muscle mass and quality.
- Published
- 2022
48. Case Report: Nintedaninb May Accelerate Lung Recovery in Critical Coronavirus Disease 2019
- Author
-
Cecilia Bussolari, Diego Palumbo, Evgeni Fominsky, Pasquale Nardelli, Rebecca De Lorenzo, Giordano Vitali, Francesco De Cobelli, Patrizia Rovere-Querini, Anna Mara Scandroglio, Bussolari, C., Palumbo, D., Fominsky, E., Nardelli, P., De Lorenzo, R., Vitali, G., De Cobelli, F., Rovere-Querini, P., and Scandroglio, A. M.
- Subjects
Oncology ,medicine.medical_specialty ,ARDS ,Medicine (General) ,Case Report ,Systemic inflammation ,chemistry.chemical_compound ,R5-920 ,Growth factor receptor ,Internal medicine ,severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) ,medicine ,Respiratory function ,Lung ,business.industry ,respiratory dysfunction ,lung inflammation ,Coronavirus disease (COVID-19) ,General Medicine ,medicine.disease ,Clinical trial ,Pneumonia ,medicine.anatomical_structure ,chemistry ,Medicine ,Nintedanib ,lung recovery ,medicine.symptom ,business ,antifibrotic therapy - Abstract
Severe Coronavirus disease 2019 (COVID-19) is characterized by acute respiratory distress syndrome (ARDS) which may lead to long-lasting pulmonary sequelae in the survivors. COVID-19 shares common molecular signatures with interstitial lung diseases (ILDs), including pro-angiogenic and tissue-remodeling mechanisms mediated by vascular endothelial growth factor receptor (VEGF-R), fibroblast growth factor receptor (FGF-R), and platelet-derived growth factor receptor (PDGF-R). Nintedanib mainly targets these factors and is approved for ILDs. Therefore, we administered nintedanib through compassionate use to three patients with COVID-19 pneumonia requiring extra-corporeal membrane-oxygenation (ECMO). Here, we describe our experience in an attempt to explore the role of nintedanib in lung recovery in COVID-19. Three obese patients aged between 42 and 52 years were started on nintedanib due to difficulty in obtaining lung function restoration and weaning from ECMO support following the removal of orotracheal intubation (OTI). Soon after the start of the treatment, systemic inflammation and respiratory function rapidly improved and ECMO support was withdrawn. Serial chest CT scans confirmed the progressive lung amelioration, also reflected by functional tests during follow-up. Nintedanib was well-tolerated by all the three patients at the dosage used for ILDs and continued for 2–3 months based on drug availability. Although caution in interpreting events is required; it is tempting to speculate that nintedanib may have contributed to modulate lung inflammation and remodeling and to sustain lung repair. Altogether, nintedanib appears as a promising agent in patients with severe COVID-19 and delayed respiratory function recovery, for whom molecularly targeted therapies are still lacking. Clinical trials are necessary to confirm our observations.
- Published
- 2021
49. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine
- Author
-
Roberta Erra, Valentina Canti, Margherita Scarrone, Giuseppe A. Ramirez, Elena Schmit, Susanna Rosa, Sara Cella, Patrizia Rovere-Querini, Sara Bordoli, Rebecca De Lorenzo, Maria Teresa Castiglioni, Canti, V., Scarrone, M., De Lorenzo, R., Ramirez, G. A., Erra, R., Bordoli, S., Cella, S., Schmit, E., Rosa, S., Castiglioni, M. T., and Rovere-Querini, P.
- Subjects
medicine.medical_specialty ,adverse pregnancy outcomes ,hydroxychloroquine ,Immunology ,Intrauterine growth restriction ,Disease ,Preeclampsia ,Systemic lupus erythematosus ,systemic lupus erythematosus ,immune system diseases ,Pregnancy ,medicine ,Immunology and Allergy ,Humans ,Lupus Erythematosus, Systemic ,skin and connective tissue diseases ,reproductive and urinary physiology ,Preterm delivery ,Fetal Growth Retardation ,Obstetrics ,business.industry ,Incidence (epidemiology) ,Incidence ,Infant, Newborn ,Pregnancy Outcome ,Hydroxychloroquine ,RC581-607 ,medicine.disease ,female genital diseases and pregnancy complications ,systemic autoimmune diseases ,Antirheumatic Agents ,embryonic structures ,Childbearing age ,Female ,Immunologic diseases. Allergy ,business ,medicine.drug - Abstract
Systemic lupus erythematosus (SLE) preferentially affects women of childbearing age. Miscarriages or fetal death, intrauterine growth restriction (IUGR), preterm delivery, preeclampsia and disease flares complicate pregnancy in SLE patients. Treatment is challenging due to the need to prevent disease exacerbations and limit obstetrical complications, while showing an acceptable safety profile for both the mother and the fetus. We collected data from 74 pregnancies in 53 SLE patients prospectively followed in a dedicated ‘Pregnancy at risk’ outpatient clinic from 2003 to 2019. Out of 74, 45 pregnancies patients were treated with hydroxychloroquine (HCQ). Mothers under HCQ therapy (HCQ+ patients) and those who did not receive HCQ (HCQ−) were homogeneous in terms of age and comorbidities. Disease activity prior to conception was slightly higher in HCQ+ patients. No significant difference was observed in terms of obstetrical history. In patients achieving a viable pregnancy, the rate of IUGR (4/39, 10% in HCQ+ vs 8/25, 32%, in HCQ− patients, p
- Published
- 2021
50. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
- Author
-
Fabio Ciceri, Giancarlo Comi, Angelo A. Manfredi, Alessandra Mandelli, Nicola Ivan Lorè, Roberto Furlan, Francesco Benedetti, Rebecca De Lorenzo, Annamaria Finardi, Cristina Tresoldi, Daniela Maria Cirillo, Massimo Filippi, Patrizia Rovere-Querini, De Lorenzo, R, Loré, Ni, Finardi, A, Mandelli, A, Cirillo, Dm, Tresoldi, C, Benedetti, F, Ciceri, F, Rovere-Querini, P, Comi, G, Filippi, M, Manfredi, Aa, and Furlan, R
- Subjects
medicine.medical_specialty ,Neurology ,Coronavirus disease 2019 (COVID-19) ,Neurofilament light ,Intermediate Filaments ,tau Proteins ,Total tau ,Asymptomatic ,Gastroenterology ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Neurofilament Proteins ,law ,Internal medicine ,UCH-L1 ,Glial Fibrillary Acidic Protein ,medicine ,Humans ,030212 general & internal medicine ,Neurofilament light chain ,Neuroradiology ,Original Communication ,Glial fibrillary acidic protein ,biology ,business.industry ,GFAP ,SARS-CoV-2 ,COVID-19 ,Intensive care unit ,biology.protein ,Neurology (clinical) ,medicine.symptom ,Tau ,business ,Ubiquitin Thiolesterase ,Biomarkers ,030217 neurology & neurosurgery - Abstract
Background and aims Patients infected with SARS-CoV-2 range from asymptomatic, to mild, moderate or severe disease evolution including fatal outcome. Thus, early predictors of clinical outcome are highly needed. We investigated markers of neural tissue damage as a possible early sign of multisystem involvement to assess their clinical prognostic value on survival or transfer to intensive care unit (ICU). Methods We collected blood from 104 patients infected with SARS-CoV-2 the day of admission to the emergency room and measured blood neurofilament light chair (NfL), glial fibrillary acidic protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and total tau protein levels. Results We found that NfL, GFAP, and tau were significantly increased in patients with fatal outcome, while NfL and UCH-L1 in those needing ICU transfer. ROC and Kaplan–Meier curves indicated that total tau levels at admission accurately predict mortality. Conclusions Blood neural markers may provide additional prognostic value to conventional biomarkers used to predict COVID-19 outcome. Supplementary Information The online version contains supplementary material available at 10.1007/s00415-021-10595-6.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.